Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment: a Randomized Controlled Trial

NCT05306652 is registered in ClinicalTrials.gov with AUSL Romagna Rimini as lead sponsor.

NCT NCT05306652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment: a Randomized Controlled Trial
Lead sponsor
AUSL Romagna Rimini
Phase
Not applicable
Overall status
Unknown status
Start date
April 4, 2022
Completion date
June 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer